Investment analysts at StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research report issued to clients and investors on Monday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Price Performance
Shares of SRNE opened at $0.01 on Monday. Sorrento Therapeutics has a 52-week low of $0.00 and a 52-week high of $0.42. The stock has a fifty day simple moving average of $0.01 and a two-hundred day simple moving average of $0.03.
Sorrento Therapeutics Company Profile
Featured Stories
- Five stocks we like better than Sorrento Therapeutics
- What Are Dividend Champions? How to Invest in the Champions
- Chipotle Mexican Grill Stock Split: Where Does it Go From Here?
- 3 Warren Buffett Stocks to Buy Now
- Arm Holdings and Micron: Top 2 AI Stocks to Buy and Hold
- Business Services Stocks Investing
- Best Buy Stock May Be Best Bought Before the Holiday Season
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.